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ABSTRACT  
Introduction: Stenotrophomonas maltophilia (S.maltophilia) has emerged as an important 
opportunistic, nosocomial pathogen capable of causing respiratory, bloodstream and urinary 
infections in a debilitated host. Prevention of acquisition and infection depends upon the 
application of modern infection-control practices. Methods: We conducted a retrospective and 
observational laboratory-based study on S. maltophilia to evaluate the distribution of these 
pathogen isolates between February 2008 and December 2012 in a 38-bed intensive care unit 
in northeastern Brazil. The study began by surveying all positive S. maltophilia cultures 
processed by the microbiology laboratory during the period of study. The cultures, originating 
from various types of biological material were processed by Vitek® System. The cultures were 
processed in protocol in accordance with CLSI -M100- S25. The incidence rate was calculated 
per 1,000 admissions. Results: A total of 100 sample isolates were tested positive for S. 
maltophilia. The isolates were obtained from 50.301 hospitalized patients (0.19%). A total of 
8.572 positive cultures were detected in different biological materials. Ninety four (94%) 
isolates were from patients in adult intensive care. Seventy (70%) S. maltophilia isolates were 
from tracheal cultures. All S. maltophilia isolates were sensitive to Co-trimoxazole and 
levofloxacin. Conclusions: This study shows the importance of other analytical epidemiologic 
studies that correlate the presence of S. maltophilia incidence associated with the risk factor, 
and the outcomes, in our region.  
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RESUMO 
 
Introdução: A Stenotrophomonas maltophilia (S.maltophilia) surgiu como um importante 
patógeno oportunista, nosocomial, capaz de causar infecções respiratórias, na corrente 
sanguínea e urinárias em um hospedeiro debilitado. A prevenção da aquisição e infecção 
depende da aplicação de modernas práticas de controle de infecção. Métodos: Foi realizado um 
estudo retrospectivo e observacional em laboratório sobre S. maltophilia para avaliar a 
distribuição desses isolados de patógenos entre fevereiro de 2008 e dezembro de 2012 em uma 
unidade de terapia intensiva de 38 leitos no nordeste do Brasil. O estudo começou com o 
levantamento de todas as culturas positivas de S. maltophilia processadas pelo laboratório de 
microbiologia durante o período de estudo. As culturas, provenientes de vários tipos de material 
biológico, foram processadas pelo sistema Vitek®. As culturas foram processadas em protocolo 
de acordo com a CLSI-M100-S25. A taxa de incidência foi calculada por 1.000 internações. 
Resultados: Um total de 100 isolados da amostra foi testado positivo para S. maltophilia. Os 
isolados foram obtidos de 50.301 pacientes hospitalizados (0,19%). Um total de 8.572 culturas 
positivas foi detectado em diferentes materiais biológicos. Noventa e quatro (94%) isolados 
eram de pacientes em tratamento intensivo adulto. Setenta (70%) isolados de S. maltophilia 
eram de culturas traqueais. Todos os isolados de S. maltophilia foram sensíveis ao cotrimoxazol 
e levofloxacina. Conclusões: Este estudo mostra a importância de outros estudos 
epidemiológicos analíticos que correlacionam a presença da incidência de S. maltophilia 
associada ao fator de risco e os desfechos em nossa região. 
 
Palavras-chave: isolados de Stenotrophomonas maltophilia; controle de infecção nosocomial; 
resistência a múltiplas drogas. 
 
1   INTRODUCTION  
Stenotrophomonas (Xanthomonas) maltophilia (S. maltophilia) is an ubiquitous, 
aerobic, non-fermentative, gram-negative bacillus that is closely related to the Pseudomonas 
species. It was first isolated in 1943 and at the time was named Bacterium bookeri, later it was 
classified within the genus Pseudomonas, then Xanthomonas, and then finally 
Stenotrophomonas in 1993. S. maltophilia is the only species of Stenotrophomonas known to 
infect humans, whereas its closest genetic relatives are plant pathogens. It is frequently isolated 
from soil, water, animals, plant matter and hospital equipment 1-9.  
The Stenotrophomonas infections have been associated with high morbidity and 
mortality in severely immunocompromised and debilitated individuals as an opportunistic 
pathogen. The risk factors associated with the Stenotrophomonas infection include admission 
to an intensive care unit (ICU), HIV infection, malignant conditions, being treated using 
chemotherapy, cystic fibrosis, neutropenia, mechanical ventilation, recent surgery, trauma, the 
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presence of an indwelling central catheter, and previous therapy with broad-spectrum antibiotics 
9. 
The major clinical syndromes associated with S. maltophilia are pneumonia and 
bacteremia which is normally secondary to other infections or consequence of invasive 
procedures during hospitalisation, such as a catheter 1-9.  
The aim of this study is to evaluate the distribution of S.maltophilia in tertiary private 
hospital tertiary care in Northeastern Brazil in a 5 year period and also identify the most 
common site of isolation of this microorganism and factors that may be related to its occurrence. 
 
2    METHODS  
This observational retrospective study was performed in a 38-bed intensive care unit 
(ICU) in northeastern Brazil. It began by surveying all positive S. maltophilia cultures processed 
by microbiology laboratory from February 2008 to December 2012.  
All patients admitted in ICU during the study period had samples collected and send to 
the microbiology laboratory for analysis. However it was not considered immunological status, 
length of stay in ICU, use of antibiotics before or during the hospitalization and diseases that 
would compromise the patient's clinical status, such as diabetes, hypertension, renal and 
respiratory diseases and cystic fibrosis. 
A database was created with the following variables: possible sites of isolation, such as 
urine, blood and tracheal aspirate, and type of Intensive Care Unit (ICU), if adult, pediatric or 
neonatal. 
Various types of biological material (blood, urine, tracheal, catheter and other sites) of 
50.301 hospitalized patients were collected. All biological material was processed by the 
microbiology laboratory. The urine was plated on CLED agar, the blood and the catheter tips 
and tracheal aspirate in 5% sheep’s blood agar (24h at 35±1°C).  
A total of 8.572 positive bacterial cultures (17.04%) were used for identification and 
antibiotic susceptibility testing in the automated system Vitek® (Biomerieux SA, France ) 10.  
During this period, all cultures originating from various types of biological material 
were processed by Vitek® System (Biomerieux SA, France). Cultures were processed in 
accordance with the CLSI (Clinical and Laboratory Standards Institute) – M100-S2510.  
 
2.1   STATISTICAL ANALYSIS  
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The statistical analysis was performed using a descriptive analysis for relative 
frequency. The incidence rate was calculated per 1,000 admissions.  
 
2.2   ETHICAL CONSIDERATIONS  
The study protocol was approved by the Institutional Ethics Committee (CAAE: 
45195415.3.0000.5200/No 1.067.721- 18/05/2015) and the resources for the development of 
the project were obtained from a private microbiology laboratory.  
 
3   RESULTS 
The results are expressed in Table 1. 
Of the 50.301 cultures collected from patients hospitalized in ICUs from February 2008 
to December 2012, 8.572 were positive to bacteria (17,04%) and only 100 samples were 
positive to S. maltophilia, which corresponds to approximately 1,17% of all positive cultures 
from that period. 
Ninety four (94%) isolates positive for S. maltophilia were isolated in adult ICU, 5 
samples (5%) were isolated in pediatric ICU and only 1 sample (1%) was from neonatal ICU. 
The most prevalent site of S. maltophilia isolation was tracheal aspirate (70%) followed by 
blood (20%). Isolation of S. maltophilia in urine, catheter and others biological materials were 
not common. 
Regarding the sensibility profile of S. maltophilia strains, the results were given by the 
microbiology laboratory and the sensibility tests were done according to standards established 
by CLSI (Clinical and Laboratory Standards Institute) - M100 - S2510. The majority of tested 
strains showed resistance to Cefotaxime (94.1%), Amikacin (90.2%), Ceftriaxone (88.2%), 
Gentamicin (82.4%) and Ceftazidime (60.8%) and almost half of the strains were resistant to 
Cefoperazone (49.0%), Piperacillin (45.1%) and Cefepime (45.1%). However, all S. 
maltophilia isolates were sensitive to Cotrimoxazole (TMP/SMX) and Levofloxacin. 
 
4   DISCUSSION  
Non-fermenting Gram-negative bacilli (NF-GNB) colonization and infection are 
frequent among critically ill patients. Antibiotic resistance is common in NF-GNB, resulting in 
inappropriate initial antibiotic treatment and poor outcomes 1,11,12,13. Several outbreaks of 
infection have been described including a few reports of infections originating outside the 
hospital setting 14,15,16,17,18.  
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Stenotrophomonas maltophilia is a non-fermentative gram-negative bacillus that can be 
isolated from clinical settings. Although S. maltophilia is related to high rates of morbidity and 
mortality especially in the ICU, because of its intrinsic resistance mechanisms to antibiotics, 
only 100 samples collected from 50.301 patients hospitalized in ICU were positive for 
Stenotrophomonas, which represents less than 0,2%, indicating that this type of infection is not 
common at the hospital where the study was conducted 2, 7. 
Although the incidence of this pathogen is small during the period of study, S. 
maltophilia occurence needs to be investigated because of its intrinsic resistance mechanisms 
and wide distribution, which makes difficult to establish its dissemination pattern. It is known 
that S. maltophilia has ability to constitute biofilm in epithelial cells, especially from the lungs, 
and medical devices, playing an important role as an etiological agent of infections in ICU 
setting. The biofilm constitution capacity is probably the reason why S. maltophilia was 
primarily isolated from tracheal aspirate (94%) 19, 20. 
It is important to understand about the S. maltophilia hospital based frequency. S. 
maltophilia can be isolated in a great variety of microenvironments, such as tap water, 
vegetables, soil and hospital settings such as respirators, suction catheters, arterial pressure 
monitors and dialysis machines 1, 12, 13, 15, 18, 21, S. maltophilia was isolated at the hospital where 
the study was conducted from tracheal aspirate, blood, urine, catheter, ocular and wound 
secretion. 
In accordance with the various sites that S. maltophilia can be isolated, the spectrum of 
infection is also large, being able to cause endocarditis, urinary tract infections, respiratory tract 
infections and bacteremia, which is considered to be secondary to gastrointestinal, urinary and 
respiratory infections. The use of intravascular device can also favor the occurrence of S. 
maltophilia in the blood, however this site of isolation (20%) was not as common as tracheal 
aspirate isolates in the population studied 1, 9, 7, 8, 22 - 27. 
Analysis of anatomical sources of isolates identified that the respiratory tract as the most 
commonly affected structured, as 70% of the isolates were from tracheal aspirate, a similar 
result of other studies that reported frequencies from 56 to 69% 7, 28, 29. Tracheostomy is an 
important procedure during ICU in patients with respiratory failure, however it can also be 
related to mechanical ventilation associated with pneumonia, elevating the risk of infections, 
especially caused by microorganisms that have the ability to colonize hospital equipments, 
including Stenotrophomonas maltophilia 29. To reduce the colonization of medical devices, it 
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is important that preventive measures are taken, such as hand washing, water and air control 
and complete disinfection of superficies. 
Although Cotrimoxazole (TMP-SMX) is the standard treatment for S. maltophilia 
infections, there may be resistance to this antibiotic, which hinders the therapeutic approach, 
hence the significance of susceptibility tests. Some studies have suggested that the multidrug 
resistance of S. maltophilia strains is not only due to the use of antibiotics during the 
hospitalization, but also due to some intrinsic mechanisms such as reduction of membrane 
permeability, multidrug efflux pumps, presence of beta-lactamases encoded by chromosomes 
and plasmids, transposons, integrons and biofilm 15, 20, 30, 31. 
S. maltophilia strains displays high Ciprofloxacin resistance, mainly due to several 
efflux systems 32-34. One recent study of clinical isolates of S. maltophilia that evaluated 38 
cases of SMB (S. maltophilia bacteremia) showed susceptibility to Levofloxacin between 
66.7% and 84.2%, and TMP/SMX between 75% and 100% 11. Other study showed resistance 
to TMP/SMX (5.4%) lower than that observed for levofloxacin (12%) for 88 S. maltophilia 
isolates 14. In this study all isolates were susceptible to Cotrimoxazole (TMP/SMX) and 
levofloxacin in accordance with CLSI 10, indicating that colonization or infection caused by S. 
maltophilia can be treated with those antibiotics. 
The major challenge related to S. maltophilia occurrence is its ability to adapt to the 
environment and to alter antimicrobial strategies to keep pace with the evolution of S. 
maltophilia. The development of studies needs to take a microbial ecology/ community 
approach to consider the interaction of S. maltophilia with host cell surfaces and antimicrobial 
defenses presented by the host and evaluate any effect on other potential pathogens colonized 
with S. maltophilia. The use of biocides in clinical/ medical settings should be carefully 
controlled to avoid encouraging the spread of biocide-tolerant S. maltophilia strains. To combat 
the increasing incidences of S. maltophilia infections in hospitals and clinics, education to 
increase awareness of health care personnel is key in preventing the transmission and spread of 
this opportunistic pathogen.  
The hygienic practice of hand washing must be continually reinforced in clinical settings 
to avoid transfer of the pathogen to the patient during clinical procedures, avoiding bacteremia. 
The avoidance of the use of hospital tap water for bathing and cleaning of wounds is a necessary 
measure of care for particularly vulnerable populations such as neonatal patients. The 
discarding of residual antibiotic solutions, residual possibly contaminated hand soap solutions, 
and patient body fluids into the hospital plumbing system should be avoided. An increased 
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vigilance for the observation and replacement of worn parts of susceptible surfaces, such as old 
deteriorating plumbing systems, can help reduce the risk of infection. Steps taken such as these 
are actions that can help lower the number of fatalities associated with S. maltophilia infections. 
The main limitation of this study is that the factors that would influence the occurrence 
of S. maltophilia in ICU, such as length of stay, use of antimicrobials, immune system status 
and medical procedures were not taken into consideration. The monotherapy or combination of 
antibiotics were also not considered. Even though epidemiological data was not collected and 
being a local observational descriptive report of sites and hospital wards where this pathogen 
was isolated , the results are relevant to show S. maltophilia prevalent sites of colonization. 
This study showed some aspects related to the incidence of S. maltophilia in intensive 
care unit in a tertiary hospital from Northeast of Brazil. Approximately 1.17% cultures were 
positive for Stenotrophomonas maltophilia and 94% isolated from adult ICU were from tracheal 
aspirate, which indicates that S. maltophilia have predilection for respiratory tract. Even though 
S. maltophilia was not associated with high rates of infection, this pathogen needs to be 
observed, and so the factors that may favor its occurrence. This study also showed that all 
isolates were sensible to the antibiotics tested (Cotrimoxazole (TMP/SMX) and levofloxacin) 
and also demonstrated the importance of conducting other clinical epidemiologic analytical 
studies that correlate the presence of S. maltophilia incidence, risk factors, and the overall 
outcome of ICU-acquired S. maltophilia, as well as the morbidity and the mortality. 
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TABLE 1. Total patients in Intensive Care Unit from February 2008 to December 2012, positive cultures, 
Stenotrophomonas maltophilia isolates and biological material which S. maltophilia was isolated 
Year Total patients 
Total positive 
cultures 
Total S. maltophilia 
isolates 
Biological 
material 
Intensive 
Care Unit 
(ICU) 
2008 8347 1319 19 Blood: 02 Adult: 18 
Urine: - Pediatric: 01 
Tracheal aspirate: 
15 
Neonatal: - 
Others*: 02  
2009 8857 1392 23 Blood: 04 Adult: 21 
Urine: - Pediatric: 02 
Tracheal aspirate: 
18 
Neonatal: - 
Others*: 03  
2010 10318 1849 22 Blood: 05 Adult: 21 
Urine: 01 Pediatric: - 
Tracheal aspirate: 
14 
Neonatal: 01 
Others*: 02  
2011 11734 2164 25 Blood: 07 Adult: 23 
Urine: - Pediatric: 02 
Tracheal aspirate: 
18 
Neonatal: - 
Others*: -  
2012 11045 1848 11 Blood: 02 Adult: 11 
Urine: 03 Pediatric: - 
Tracheal aspirate: 
05 
Neonatal: - 
Others*: 01  
(*) Others: 2008 - Pulmonary/ Catheter; 2009 - Catheter; 2010 - Ocular (newborn)/ Catheter; 2012 - Wound 
 
